Collegium Pharmaceutical, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of COLL for the last quarter is 144.92 M USD, and it's 3.22% lower compared to the previous quarter. The net income of Q1 24 is 27.71 M USD.